BRCA1/2 pathogenic variants are associated with an increased risk of male breast, pancreatic, and stomach cancer.
1. Pathogenic variants of BRCA1 or BRCA2 are associated with an increased risk of pancreatic and stomach cancer in both sexes 2. Only BRCA2 carriers have an increased risk of prostate cancer Evidence Rating Level: 2 (Good) Study Rundown: Pathogenic variants (PVs) of BRCA1 and BRCA2 are known to be associated with an increased risk […]
Read More